Skip to main content

Advertisement

Log in

Extensive cortico-subcortical lesions in Wilson’s disease: clinico-pathological study of two cases

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Wilson’s disease (WD) with extensive cortico-subcortical lesions represents a rare neuropathological subgroup, the pathogenesis of which is not clearly determined. We report two new cases with identical lesions. In the families of each of the patient, there were mutations in the ATPase7B gene, especially in the family of proband 1, and in the first cousin of proband 2. These cases included massive destruction of the white matter in superior gyri, mostly frontal, extending to the deep cortex with neuronal loss and capillary proliferation. Astrocytes were of Alzheimer type 1 and 2; and type 1 were labeled by anti-metallothionein. Opalski cells were abundant and their macrophagic lineage was confirmed by immunostaining. Among the possible mechanisms proposed, the role of vascular factors and penicillamine treatment could be excluded. Cerebral copper content in white matter and putamen of case 1 was at the same level as in common WD but accumulation of unbound copper in the white matter was a distinctive feature, which suggested a pathological neurotoxic effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Aisen AM, Martel W, Gabrielsen TO, Glazer GM, Brewer G, Young AB, Hill G (1985) Wilson disease of the brain: MR imaging. Radiology 157:137–141

    PubMed  Google Scholar 

  2. Alajouanine T, Bertrand I, Boudin G, Pepin B (1955) Etude anatomo-clinique, biologique et chimique d’un cas de pseudo-sclérose de Westphal-Strumpell. Rev Neurol (Paris) 93:701–729

    Google Scholar 

  3. Anton G 1908 cited by Finlayson and Superville

  4. Anzil AP, Herrlinger H, Blinzinger K, Heldrich A (1974) Ultrastructure of brain and nerve biopsy tissue in Wilson disease. Arch Neurol 31:94–100

    PubMed  Google Scholar 

  5. Brewer GJ, Terry CA, Aisen AM, Hill GM (1987) Worsening of neurologic syndrome in patients with Wilson’s disease with initial penicillamine therapy. Arch Neurol 44:490–493

    PubMed  Google Scholar 

  6. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5:327–337

    Article  PubMed  Google Scholar 

  7. Bush VJ, Moyer TP, Batts KP, Parisi JE (1995) Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. Clin Chem 41:284–294

    PubMed  Google Scholar 

  8. Butterworth RF (1992) Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig Dis Sci 37:321–327

    Article  PubMed  Google Scholar 

  9. Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 17:221–227

    Article  PubMed  Google Scholar 

  10. Cavanagh JB, Harding BN (1994) Pathogenic factors underlying the lesions in Leigh’s disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 117:1357–1376

    PubMed  Google Scholar 

  11. Chu NS (1989) Clinical, CT and evoked potential manifestations in Wilson’s disease with cerebral white matter involvement. Clin Neurol Neurosurg 91:45–51

    PubMed  Google Scholar 

  12. Cumings JN (1949) The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain 71:410–415

    Google Scholar 

  13. Duc HH, Hefter H, Stremmel W, Castaneda-Guillot C, Hernandez Hernandez A, Cox DW, Auburger G (1998) His1069Gln and six novel Wilson disease mutations: analysis of relevance for early diagnosis and phenotype. Eur J Hum Genet 6:616–623

    PubMed  Google Scholar 

  14. Ferenci P (1999) Wilson’s disease. Ital J Gastroenterol Hepatol 31:416–425

    PubMed  Google Scholar 

  15. Finlayson MH, Superville B (1981) Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain 104:79–95

    PubMed  Google Scholar 

  16. Gitlin JD (2003) Wilson disease. Gastroenterology 125:1868–1877

    PubMed  Google Scholar 

  17. Gu M, Cooper JM, Butler P, Walker AP, Mistry PK, Dooley JS, Schapira AH (2000) Oxidative-phosphorylation defects in liver of patients with Wilson’s disease. Lancet 356:469–474

    Article  PubMed  Google Scholar 

  18. Hall H (1921) La dégénérescence hépato-lenticulaire: maladie de Wilson—pseudo-sclérose. Masson, Paris

  19. Hermann W, Caca K, Eggers B, Villmann T, Clark D, Berr F, Wagner A (2002) Genotype correlation with fine motor symptoms in patients with Wilson’s disease. Eur Neurol 48:97–101

    Article  PubMed  Google Scholar 

  20. Homen EA 1892 cited by Finlayson and Superville

  21. Horoupian DS, Sternlieb I, Scheinberg IH (1988) Neuropathological findings in penicillamine-treated patients with Wilson’s disease. Clin Neuropathol 7:62–67

    PubMed  Google Scholar 

  22. Huang CC, Chu NS (1992) Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson’s disease: report of a case. J Formos Med Assoc 91:627–629

    PubMed  Google Scholar 

  23. Ishino H, Mii T, Hayashi Y, Saito A, Otsuki S (1972) A case of Wilson’s disease with enormous cavity formation of cerebral white matter. Neurology 22:905–909

    PubMed  Google Scholar 

  24. Konowalow N (1941) Histopathologie der hepato-lentikulären Degeneration. Z Ges Neurol Psychiatr 171:200–228

    Google Scholar 

  25. Lawler GA, Pennock JM, Steiner RE, Jenkins WJ, Sherlock S, Young IR (1983) Nuclear magnetic resonance (NMR) imaging in Wilson disease. J Comput Assist Tomogr 7:1–8

    PubMed  Google Scholar 

  26. Leigh D (1951) Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14:216–221

    PubMed  Google Scholar 

  27. Loudianos G, Dessi V, Lovicu M, Angius A, Nurchi A, Sturniolo GC, Marcellini M, Zancan L, Bragetti P, Akar N, Yagci R, Vegnente A, Cao A, Pirastu M (1998) Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat 12:89–94

    Article  PubMed  Google Scholar 

  28. Maier-Dobersberger T, Ferenci P, Polli C, Balac P, Dienes HP, Kaserer K, Datz C, Vogel W, Gangl A (1997) Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med 127:21–26

    PubMed  Google Scholar 

  29. Nayrac P, Graux P, Van Bogaert L, Rabache R (1957) Etude biochimique et histologique sur une fratrie wilsonienne d’une stricte homotypie anatomoclinique. Rev Neurol (Paris) 96:196–215

    Google Scholar 

  30. Richter R (1948) The pallial component in hepato-lenticular degeneration. J Neuropathol Exp Neurol 7:1–18

    Google Scholar 

  31. Schulman S (1968) Wilson’s disease. In: Minckler J (ed) Pathology of the nervous system, vol 1. McGraw-Hill, New York, pp 1139–1162

  32. Schulman S, Barbeau A (1963) Wilson’s disease: a case with almost total loss of white matter. J Neuropathol Exp Neurol 22:105–119

    PubMed  Google Scholar 

  33. Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, Parano E, Pavone L, Evgrafov O, Ivanova-Smolenskaya IA, Anneren G, Westermark K, Urrutia FH, Penchaszadeh GK, Sternlieb I, Scheinberg IH, Gilliam TC, Petrukhin K (1997) Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 61:317–328

    PubMed  Google Scholar 

  34. Sheline CT, Choi EH, Kim-Han JS, Dugan LL, Choi DW (2002) Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo. Ann Neurol 52:195–204

    Article  PubMed  Google Scholar 

  35. Shimoji A, Miyakawa T, Watanabe K, Yamashita K, Katsuragi S, Kabashima K (1987) Wilson’s disease with extensive degeneration of cerebral white matter and cortex. Jpn J Psychiatry Neurol 41:709–717

    PubMed  Google Scholar 

  36. Sparaco M, Bonilla E, DiMauro S, Powers JM (1993) Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 52:1–10

    PubMed  Google Scholar 

  37. Spielmeyer W (1920) Die histopathologische Zusammenhörigkeit der Wilsonschen Krankheit. Z Ges Neurol Psychiatr 57:312–351

    Google Scholar 

  38. Starosta-Rubinstein S, Young AB, Kluin K, Hill G, Aisen AM, Gabrielsen T, Brewer GJ (1987) Clinical assessment of 31 patients with Wilson’s disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol 44:365–370

    PubMed  Google Scholar 

  39. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM (1993) The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5:344–350

    Article  PubMed  Google Scholar 

  40. Thomas GR, Roberts EA, Walshe JM, Cox DW (1995) Haplotypes and mutations in Wilson disease. Am J Hum Genet 56:1315–1319

    PubMed  Google Scholar 

  41. Walker JM, Tsivkovskii R, Lutsenko S (2002) Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson’s disease protein and regulates its catalytic activity. J Biol Chem 277:27953–27959

    Article  PubMed  Google Scholar 

  42. Wang XF, Cynader MS (2001) Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J Neurosci 21:3322–3331

    PubMed  Google Scholar 

  43. White AR, Multhaup G, Maher F, Bellingham S, Camakaris J, Zheng H, Bush AI, Beyreuther K, Masters CL, Cappai R (1999) The Alzheimer’s disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J Neurosci 19:9170–9179

    PubMed  Google Scholar 

  44. Wilson S (1912) Progressive lenticular degeneration:a familial nervous disease associated with cirrhosis of the liver. Brain 34:295–507

    Google Scholar 

  45. Yoshii F, Takahashi W, Shinohara Y (1996) A Wilson’s disease patient with prominent cerebral white matter lesions: five-year follow-up by MRI. Eur Neurol 36:392–393

    PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank Prof. F. Gray and Dr. A. Lombes for special techniques, P. Castagnet and C. Poiron for excellent technical assistance, M.-L. Peyronnet for typing the manuscript and D. Robinson and M. O’Gara for linguistic help.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jacqueline Mikol.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mikol, J., Vital, C., Wassef, M. et al. Extensive cortico-subcortical lesions in Wilson’s disease: clinico-pathological study of two cases. Acta Neuropathol 110, 451–458 (2005). https://doi.org/10.1007/s00401-005-1061-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-005-1061-1

Keywords

Navigation